Main Menu

News and features 

Read the latest stories about our world-leading research, science, fundraising and philanthropy

To find out more, you can contact our media team, follow us on social media or visit our press release archive.

Sign up for our newsletters


Scientists uncover promising new treatment strategy for aggressive form of leukaemia 18

Scientists have uncovered a promising treatment strategy for an aggressive type of leukaemia – through targeting the enzymes that cells normally use to sense and adapt to changing oxygen levels. Find out more

Shape-shifting cancer cell discovery reveals two potential drug targets against skin cancer 17

Scientists have discovered how skin cancer cells shapeshift based on their environment – enabling them to spread through the body and cause a metastatic cancer. Find out more

Ride announced in memory of Hairy Biker Dave Myers to support The Institute of Cancer Research 15

The Institute of Cancer Research, London, is honoured to be a beneficiary of a motorbike ride in tribute to Dave Myers of the Hairy Bikers. The ride will take place on Saturday 8 June 2024. Find out more

See all news articles


Scientific achievements of 2023 05

We've selected a range of discoveries from the academic year that highlight the quality and breadth of our basic, translational and clinical research. Find out more

Untapping the full potential of immunotherapies for more people with cancer 06

Immunotherapy works by sparking the body’s own immune system into action against tumours. It has become a first-choice treatment for some types of cancer, and now there are exciting opportunities to unlock its benefits for more patients through research. Jane Shepley explores the story behind immunotherapy and how we can untap its potential. Find out more

Over a decade of abiraterone: the drug that revolutionised advanced prostate cancer care 14

This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the drug’s discovery, how a landmark trial changed the way advanced prostate cancer is treated today, and what the drug has meant for patients who are currently treated with it. Find out more

See all feature articles